期刊文献+
共找到6篇文章
< 1 >
每页显示 20 50 100
基于种族、CRP和血药浓度进行氯氮平成人个体化剂量滴定降低不良反应国际指南(全译)
1
作者 Jose de Leon Georgios Schoretsanitis +101 位作者 Robert L.Smith Espen Molden Anssi Solismaa Niko Seppäla Miloslav Kopecek Patrik Svancer Ismael O.lmos Carina Ricciardi Celso Iglesias-Garcia Ana Iglesias-Alonso Edoardo Spina Can-Jun Ruan Chuan-Yue Wang Gang Wang Yi-Lang Tang Shih-Ku Lin Hsien-Yuan Lane Yong Sik Kim Se Hyun Kim Anto P.Rajkumar Dinora F.González-Esquivel Helgi Jung-Cook Trino Baptista Christopher Rohde Jimmi Nielsen Hélène Verdoux Clelia Quiles Emilio J.Sanz Carlos De las Cuevas Dan Cohen Peter E.J.Schulte Aygun Ertugrul A.Elif Anil Yagcoglu Nitin Chopra Betsy McCollum Charles Shelton Robert O.Cotes Arun R.Kaithi John M.Kane Saeed Farooq Chee H.Ng John Bilbily Christoph Hiemke Carlos López-Jaramillo Ian McGrane Fernando Lana Chin B.Eap Manuel Arrojo-Romero Flavian Stefan Radulescu Erich Seifritz Susanna Every-Palmer Chad A.Bousman Emmanuel Bebawi Rahul Bhattacharya Deanna L.Kelly Yu Otsuka Judit Lazary Rafael Torre Agustin Yecora Mariano Motuca Sherry Kit Wa Chan Monica Zolezzi Sami Ouanes Domenico De Berardis Sandeep Grover Ric M.Procyshyn Richard A.Adebayo Oleg O.Kirilochev Andrey Soloviev Konstantinos N.Fountoulakis Alina Wilkowska Wiestaw Jerzy Cubala Muhammad Ayub Alzira Silva Raphael M.Bonelli José María Villagrán-Moren Benedicto Crespo-Facorro Henk Temmingh Eric Decloedt Maria Rosel Pedro Hiroyoshi Takeuchi Masaru Tsukahara Gerhard Gründer Marina Sagud Andreja Celofiga Dragana Ignjatovic Ristic Bruno Bertolucci Ortiz Helio Elkis António JoséPacheco Palha Adrián Lerena Emilio Fernandez-Egea Dan Siskind Abraham Weizman Rim Masmoudi Shamin Mohd Saffian Jonathan G.Leung Peter F.Buckley Stephen R.Marder Leslie Citrome Oliver Freudenreich Christoph U.Correll Daniel J.Müller 《中华精神科杂志》 北大核心 2026年第2期87-113,共27页
本国际指南提议,在全球范围内的氯氮平药品说明书中加入基于种族背景的给药剂量与滴定方案,以完善氯氮平药品说明书。美国药品不良反应数据库显示,氯氮平在美国属于第三大毒性药物,在世界范围内所致肺炎造成的死亡人数是其所致粒细胞缺... 本国际指南提议,在全球范围内的氯氮平药品说明书中加入基于种族背景的给药剂量与滴定方案,以完善氯氮平药品说明书。美国药品不良反应数据库显示,氯氮平在美国属于第三大毒性药物,在世界范围内所致肺炎造成的死亡人数是其所致粒细胞缺乏或心肌炎死亡人数的4倍多。氯氮平治疗参考浓度范围窄(稳态谷浓度范围:350~600 ng/ml),随着浓度的增加,不良反应和毒性反应也可能增加。氯氮平主要由细胞色素P4501A2酶(Cytochrome P4501A2,CYP1A2)代谢,因此女性非吸烟者需要的剂量最低,而男性吸烟者需要的剂量最高。合并使用CYP1A2酶抑制剂(如口服避孕药、丙戊酸)、肥胖或感染(C反应蛋白浓度升高)可能与CYP1A2的表型转换为慢代谢型有关。亚裔(译者注:指地理分布从巴基斯坦到日本的人群)或美洲原住民印第安人的CYP1A2活性较低,需要较低的氯氮平剂量就能达到350 ng/ml的浓度。在美国,氯氮平的推荐日剂量为300~600 mg/d。氯氮平缓慢个体化滴定给药可以预防给药早期不良反应(包括晕厥、心肌炎和肺炎等)。本指南为美国住院患者提供了6项个体化滴定方案建议:①慢代谢型的亚裔/美洲原住民(如肥胖或合用丙戊酸),需要最低治疗剂量(minimum therapeutic dose,MTD)75~150 mg/d;②正常代谢型的亚裔/美洲原住民,需要MTD为175~300 mg/d;③慢代谢型的欧洲/西亚裔(如肥胖或合用丙戊酸),需要MTD为100~200 mg/d;④正常代谢型的欧洲/西亚裔(West Asian ethnicity)(译者注:涵盖伊朗、伊拉克、沙特阿拉伯、土耳其等国家),需要MTD为250~400 mg/d;⑤除亚裔或美洲原住民以外的慢代谢型美国人(如肥胖或合用丙戊酸),需要MTD为150~300 mg/d;⑥除亚裔或美洲原住民以外的正常代谢型美国人,需要MTD为300~600 mg/d。使用氯氮平治疗的患者,在服药前和服药后至少4周,需每周监测C反应蛋白来判断是否存在感染,包括由氯氮平滴定速度过快导致的感染。 展开更多
关键词 原住民-美国大陆族裔、亚洲大陆族裔-氯氮平 不良反应-氯氮平 血液-氯氮平 代谢-氯氮平 治疗用途-氯氮平 不良反应-CYP1A2-药物说明书-欧洲大陆族裔-感染-炎症-死亡率 药物效应-性别-吸烟
原文传递
苯丙胺类兴奋剂滥用的治疗研究进展 被引量:29
2
作者 江海峰 赵敏 +2 位作者 孙海明 王石斌 Walter Ling 《中国药物依赖性杂志》 CAS CSCD 2008年第4期259-262,共4页
关键词 苯丙胺类兴奋剂 中枢神经系统兴奋剂 苯丙胺类精神兴奋剂 苯丙胺类中枢兴奋剂 甲基苯丙胺 治疗 苯丙胺类物质 精神活性物质
暂未订购
Dose,Plasma Level,and Treatment Outcome Among Methadone Patients in Shanghai,China 被引量:1
3
作者 Haifeng Jiang Maureen Hillhouse +7 位作者 Jiang Du Shujun Pan Ang Alfonso Jun Wang Zhirong Zhou Weijun Yuan Walter Ling Min Zhao 《Neuroscience Bulletin》 SCIE CAS CSCD 2016年第6期538-544,共7页
Abstract The purpose of this study was to investigate the blood levels of methadone in participants receiving methadone for the treatment of opioid dependence. After stabilization on methadone for four weeks, blood sa... Abstract The purpose of this study was to investigate the blood levels of methadone in participants receiving methadone for the treatment of opioid dependence. After stabilization on methadone for four weeks, blood samples from 95 participants were collected between treatment weeks 4 and 12, before and after receiving doses of methadone, and its blood levels were measured. A multiple linear regression model was used to examine the associa- tion between methadone blood levels and the outcomes of methadone maintenance treatment (MMT). Outcome dif- ferences between participants who had high (≥2) or low (〈2) peak-to-trough ratios were also compared using an independent sample t-test. The blood level of methadone was not correlated with the clinical outcome of MMT with the moderate range of doses given. However, the retention of patients who had a free peak-to-trough ratio 〉2 was significantly poorer than those whose ratio was 〈2. Thus, monitoring plasma methadone levels is unlikely to be effective for guiding dosing decisions in situations where compliance with MMT is already very high or when themethadone dose is no longer the dominant factor in determining the clinical outcome. However, monitoring plasma methadone levels is still helpful for guiding the dosage for patients with a rapid metabolism. 展开更多
关键词 METHADONE Plasma level TREATMENTOUTCOME METABOLISM
原文传递
Drug-abusing Offenders with Co-morbid Mental Disorders:Gender Differences in Problem Severity,Treatment Participation,and Recidivism
4
作者 DU Jiang HUANG David +1 位作者 ZHAO Min HSER Yih Ing 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2013年第1期32-39,共8页
Objective This study examined the gender differences in drug‐related problems and predictors of recidivism among a sample of 1444 offenders with co‐morbid drug abuse and mental disorders participating in California... Objective This study examined the gender differences in drug‐related problems and predictors of recidivism among a sample of 1444 offenders with co‐morbid drug abuse and mental disorders participating in California's Proposition 36 Program.Methods Background characteristics and problem severity in multiple key life areas were assessed at intake by using Addiction Severity Index,and drug treatment participation,mental health diagnoses and arrests were based on official records.Results Women demonstrated greater problem severity than men in family relationships,health,psychological health,and sexual and physical abuse history.Men on the other hand had greater criminal history,high rates of attention disorder,and psychotic disorder.More men than women were rearrested during the year after treatment admission.Logistic regression analyses showed that for the combined sample,male,young age,cocaine use(relative to methamphetamine),drug abuse severity,methadone treatment,arrest history and fewer prior treatment history were associated with higher recidivism at 12‐month follow‐up;lower education,cocaine use,and arrest history were related to women's recidivism,while young age,outpatient treatment,and arrest history were predictors of men's recidivism.Conclusion Although the specific type of mental disorder did not seem to be predictive of recidivism,the high rates of mental health disorder and arrest of this population is problematic.Intervention strategies taking into consideration gender‐specific problems and needs can improve outcomes for both. 展开更多
关键词 Drug abuse OFFENDER Mental disorder Gender difference
暂未订购
Cannabis and Psychosis: A Review of the Risk Factors Involved
5
作者 Mohamed Ben Amar 《American Journal of Plant Sciences》 2020年第12期1949-1990,共42页
Abundant literature suggests the hypothesis that cannabis use leads to the onset of psychotic symptoms. However, the nature of the association and the causal link remain controversial. This review aims to identify the... Abundant literature suggests the hypothesis that cannabis use leads to the onset of psychotic symptoms. However, the nature of the association and the causal link remain controversial. This review aims to identify the risk factors involved in the etiopathogenesis of psychosis or psychotic features. Our electronic search found 1653 studies published until March 1<sup><span style="font-family:Verdana;">st</span></sup><span style="font-family:Verdana;"> 2020. Longitudinal studies and literature reviews were selected if they addressed specifically the issues of the cannabis/psychosis relationship and the eventual risk factors involved. Our systematic review identified six potential risk factors involved in the association. They are, in decreasing importance, the dose-response relationship (quantity, frequency and duration of cannabis use), the early age of cannabis consumption, genetic susceptibility, childhood trauma, cigarette smoking and urban environment. In contrast, a significant inverse relationship exists between cannabidiol (CBD) and psychosis: cannabidiol is associated with less psychotic symptoms and manifests antipsychotic properties. Further studies are needed to establish a clear causal relationship between cannabis and psychosis and to identify the qualitative and quantitative contribution of specific risk factors on its onset and sustainability.</span> 展开更多
关键词 CANNABIS Marijuana Hashish PSYCHOSIS SCHIZOPHRENIA Risk Factors
暂未订购
阿片依赖的循证药物治疗:从研究到应用
6
作者 Walter LING 《中国药物依赖性杂志》 CAS CSCD 2009年第4期343-343,共1页
上世纪60年代美沙酮的诞生给阿片成瘾的治疗带来了巨大的变化。目前,已有3种药物被研究证实为有效:美沙酮、纳曲酮和丁丙诺啡。本文将介绍这些药物,讨论它们如何起效,它们之间的相似之处和差异,以及是什么决定了它们在临床应用中的成功... 上世纪60年代美沙酮的诞生给阿片成瘾的治疗带来了巨大的变化。目前,已有3种药物被研究证实为有效:美沙酮、纳曲酮和丁丙诺啡。本文将介绍这些药物,讨论它们如何起效,它们之间的相似之处和差异,以及是什么决定了它们在临床应用中的成功或失败。尽管被证实的安全性和有效性对每一种成功的药物治疗方法都是必要的,但只有这些不足以确保临床上成功的应用。在被患者接受之前,社会的态度和政策有力地影响了某种药物在社会层面上被接受还是拒绝。最终,任何一种阿片依赖药物治疗方法的成功或失败依赖于社会如何看待阿片成瘾、成瘾者,以及必须为他们所做的事情。 展开更多
关键词 循证医学 阿片依赖 药物治疗
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部